Alflutinib mesylate

Alflutinib (AST2818 mesylate) mesylate is is a potent inhibitor of EGFR. Alflutinib (Furmonertinib) mesylate inhibits EGFR active mutations as well as the T790M acquired resistant mutation.


Cat. No.: EX-A2864	Purity: >98%

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
50mg	500	In-stock
100mg	700	In-stock
200mg	900	In-stock
500mg	1350	In-stock
1g	1950	In-stock
5g	4950	In-stock

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


Synonyms	AST2818 mesylate
CAS No.	2130958-55-1
Purity	>98%
Formula	C29H35F3N8O5S
Mol Weight	664.699
Appearance	solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Y.Shi, et al. P2.03-028 Third Generation EGFR Inhibitor AST2818 (Alflutinib) in NSCLC Patients with EGFR T790M Mutation: A phase1/2 Multi-Center Clinical Trial. J Thorac Oncol. 2017 Nov, 12(11): S2138.
CoA	CoA of Alflutinib mesylate

Smiles:	CS(O)(=O)=O.CN(C)CCN(C)C1=NC(OCC(F)(F)F)=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C1NC(=O)C=C


		Search